Insider Buying and Selling - GLUE

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
01/07/2026 10b5-1	01/09/2026	Warmuth Markus President & CEO CEO Director	Sell	-5,466 @ $23.49	($128,372.57)	618,937	(-0.88%)	Direct
01/05/2026	01/05/2026	Champoux Jennifer Chief Operating Officer Officer	Sell	-2,629 @ $15.17	($39,881.93)	62,371	(-4.04%)	Direct
01/05/2026	01/05/2026	Dunn Edmund Principal Accounting Officer Officer	Sell	-1,039 @ $15.17	($15,761.63)	22,693	(-4.38%)	Direct
01/05/2026	01/05/2026	Janku Filip Chief Medical Officer Officer	Sell	-3,155 @ $15.17	($47,861.35)	75,026	(-4.04%)	Direct
01/05/2026	01/05/2026	Nickson Philip Chief Business & Legal Officer Officer	Sell	-3,155 @ $15.17	($47,861.35)	60,845	(-4.93%)	Direct
01/05/2026	01/05/2026	Townson Sharon Chief Scientific Officer Officer	Sell	-3,155 @ $15.17	($47,861.35)	67,845	(-4.44%)	Direct
01/05/2026	01/05/2026	Warmuth Markus President & CEO CEO Director	Sell	-10,135 @ $15.17	($153,747.95)	624,403	(-1.60%)	Direct
06/03/2025	06/04/2025	Dunn Edmund Principal Accounting Officer Officer	Sell	-2,062 @ $4.45	($9,174.46)	23,732	(-7.99%)	Direct
03/24/2025	03/25/2025	Leo Chandra P. Director	Buy	10,000 @ $5.84	$58,383.00	10,000	(100.00%)	Direct

Monte Rosa Therapeutics, Inc. - GLUE